Novo Nordisk Health News Roundup: Nvidia deepens bets on AI in drug discovery with Recursion investment; US FDA reviewing concerns over Logan Paul’s PRIME energy drink and more
Novo Nordisk Policy and Medicine Compliance Update June 2023 Issue Features Update on Precision Lens Kickback Case, Novo Nordisk Legal Issues, Good RX FTC Case, and AI Compliance
Novo Nordisk Novo Nordisk to support MIT postdocs working at the intersection of AI and life sciences | MIT News
Novo Nordisk Policy and Medicine Compliance Update May 2023 Issue Features: Regulatory Challenges in Diversity in Clinical Trials, Embracing Generative Artificial Intelligence, Novo Nordisk’s Trans-Atlantic Speech Woes, and The Sixth Circuit Tackles the Meaning of Remuneration in Kickback Cases
